ReviewExpert review of molecular diagnostics2012
Progress in circulating tumor cell capture and analysis: implications for cancer management.
Review in Expert review of molecular diagnostics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed.
- Microfluidic Applications in Prostate Cancer Research.Micromachines · 2024Review
- Dual targeting negative enrichment strategy for highly sensitive and purity detection of CTCs.Frontiers in chemistry · 2024Article
- Role of Circulating Tumor Cells in Determining Prognosis in Metastatic Breast Cancer.South Asian journal of cancer · 2023Article
- miR-205-5p Downregulation andInternational journal of molecular sciences · 2021Article
- Advances in Multiplexed Paper-Based Analytical Devices for Cancer Diagnosis: A Review of Technological Developments.Advanced materials technologies · 2021Article
- Local Anesthetics and Recurrence after Cancer Surgery-What's New? A Narrative Review.Journal of clinical medicine · 2021Review
- Photoacoustic detection of circulating melanoma cells in late stage patients.Journal of innovative optical health sciences · 2020Article
- MAGE-A genes as predictors of the outcome of laryngeal squamous cell carcinoma.Oncology letters · 2020Article
- Liquid biopsy in pancreatic cancer: the beginning of a new era.Oncotarget · 2018Review
- MAGE-A gene expression in peripheral blood serves as a poor prognostic marker for patients with lung cancer.Thoracic cancer · 2018Article
- Melanoma antigen-encoding gene family member A1-6 and hTERT in the detection of circulating tumor cells following CD45Oncology letters · 2017Article
- Overexpression of syndecan-1, MUC-1, and putative stem cell markers in breast cancer leptomeningeal metastasis: a cerebrospinal fluid flow cytometry study.Breast cancer research : BCR · 2017Article
- Dual-Functional Lipid Coating for the Nanopillar-Based Capture of Circulating Tumor Cells with High Purity and Efficiency.Langmuir : the ACS journal of surfaces and colloids · 2017Article
- A portable optical reader and wall projector towards enumeration of bio-conjugated beads or cells.PloS one · 2017Article
- Liquid biopsy in patients with pancreatic cancer: Circulating tumor cells and cell-free nucleic acids.World journal of gastroenterology · 2016Review
- Genomic and Epigenomic Alterations in Cancer.The American journal of pathology · 2016Review
- Interaction between circulating cancer cells and platelets: clinical implication.Chinese journal of cancer research = Chung-kuo yen cheng yen chiu · 2015Review
- Nanotechnology for enrichment and detection of circulating tumor cells.Nanomedicine (London, England) · 2015Review
- Improving pancreatic cancer diagnosis using circulating tumor cells: prospects for staging and single-cell analysis.Expert review of molecular diagnostics · 2015Review
- SELEX aptamer used as a probe to detect circulating tumor cells in peripheral blood of pancreatic cancer patients.PloS one · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The hematogenous dissemination of cancer and development of distant metastases is the cause of nearly all cancer deaths. Detection of circulating tumor cells (CTCs) as a surrogate biomarker of metastases has gained increasing interest. There is accumulating evidence on development of novel technologies for CTC detection, their prognostic relevance and their use in therapeutic response monitoring. Many clinical trials in the early and metastatic cancer setting, particularly in breast cancer, are including CTCs in their translational research programs and as secondary end points. We summarize the progress of detection methods in the context of their clinical importance and speculate on the possibilities of wider implementation of CTCs as a diagnostic oncology tool, the likelihood that CTCs will be used as a useful biomarker, especially to monitor therapeutic response, and what may be expected from the future improvements in technologies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.